tiprankstipranks
Advertisement
Advertisement
Chimeric Therapeutics Updates Capital Structure After Option Expiry
PremiumCompany AnnouncementsChimeric Therapeutics Updates Capital Structure After Option Expiry
2M ago
Chimeric Therapeutics Issues 10 Million Long-Dated Unquoted Options
Premium
Company Announcements
Chimeric Therapeutics Issues 10 Million Long-Dated Unquoted Options
2M ago
Chimeric Therapeutics Issues New Shares Under Corporations Act Disclosure Exemption
Premium
Company Announcements
Chimeric Therapeutics Issues New Shares Under Corporations Act Disclosure Exemption
2M ago
Chimeric Therapeutics Advances Lead CAR T Program and Reports Strong CORE-NK Trial Data
PremiumCompany AnnouncementsChimeric Therapeutics Advances Lead CAR T Program and Reports Strong CORE-NK Trial Data
2M ago
Chimeric Therapeutics Finalises ASX Security Consolidation
Premium
Company Announcements
Chimeric Therapeutics Finalises ASX Security Consolidation
2M ago
Chimeric Therapeutics Secures Shareholder Approval for Capital Consolidation
Premium
Company Announcements
Chimeric Therapeutics Secures Shareholder Approval for Capital Consolidation
2M ago
Chimeric Therapeutics Restructures Warrant Issue With Unchanged Total Value
PremiumCompany AnnouncementsChimeric Therapeutics Restructures Warrant Issue With Unchanged Total Value
3M ago
Chimeric Therapeutics to Consolidate Shares and Equity Securities
Premium
Company Announcements
Chimeric Therapeutics to Consolidate Shares and Equity Securities
3M ago
Chimeric Therapeutics Sets Hybrid Extraordinary General Meeting for April 2026
Premium
Company Announcements
Chimeric Therapeutics Sets Hybrid Extraordinary General Meeting for April 2026
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100